麻豆传媒

Dr Othman Al Musaimi assumed the role of Lecturer in Medicinal Chemistry at the School of Pharmacy in September 2023. Dr Al Musaimi is also Vice President and Co-Founder of , a spin-out company established in collaboration with Imperial College London. Before joining this position, he worked as a Research Associate at Imperial College London. Dr Al Musaimi holds a PhD in Pharmaceutical Chemistry from the University of Kwazulu-Natal in South Africa. His research interests primarily revolve around the development of synthetic, greening, separation, purification methodologies as well as drug discovery and delivery of peptides.

Professional Affiliations

• Fellow of Higher Education Academy (FHEA).
• Honorary Associate Fellow.
• Translational and Clinical Research Institute Fellow.
• Community Associate, ACS.
• UKRI Talent Peer Review College Member.
• European Peptide Society (EPS).
• Royal Society of Chemistry Affiliate.
• American Peptide Society (APS).

Academic roles

• Academic Lead for Peer Mentoring.
• Duputy Admissions Tutor.
• MRes Programme Lead

Check my for available PhD opportunities

Othman's research interests center on developing innovative methodologies for the synthesis, separation, and purification of peptides, as well as engineering peptides for therapeutic and aesthetic applications.

Funds

• 2025

1. PI: Deep Technology Prime: Imperial College London.

• 2024

1. RSC Researcher Development and Travel Grant
2. Co-PI: Adventurous Manufacturing Grant - Round 3: EPSRC
3. PI: Research Excellence Development Award: 麻豆传媒

• 2023   

1. PI: Seed Fund: Imperial College London
2. PI: Deep Technology Prime: Imperial College London

• 2021

1. Co-I: Julia Higgins Engineering Postdoc Collaborative Research Fund: Imperial College London

• 2022

1. PI: Dame Julia Higgins Engineering Postdoc Collaborative Research Fund: Imperial College London

• 2015

1. PI: Research & Development Grant: King Abdulaziz City for Science and Technology (KACST)

Awards

1. Winner:
2. Winner: Unsung Heroes - Advancement of Knowledge - C-DICE, the Centre for Postdoctoral Development in Infrastructure Cities and Energy
3. Travel Grant Winner: 28^th American Peptide Symposium. Peptide at the Frontier. Scottsdale, AZ – June 24 – 29, 2023. 
4. Winner: Creating a Positive Research Environment - Imperial College London
5. Winner: Departmental Team Gold Award - Department of Chemical Engineering - Imperial College London
6. Travel Grant Winner: 27^th American Peptide Symposium. Peptide Science at the Summit. Whistler, BC – June 11 – 16, 2022

MPharm Students

2025/2026

1. Amy Armstrong: Tuneable Release of Anti-Aging Actives from Elastin-Derived Peptide Hydrogel Depots
2. Nubonaga Okunola: Tuneable Release of Anti-Aging Actives from Elastin-Derived Peptide Hydrogel Depots
3. Mahdi Khoshkholgh: From Defence to Therapy: Exploring the Potential of Antimicrobial Peptides
4. Fleur Coburn: Using short peptide-based technology to specifically target mTOR signalling in a neuronal model
5. Alicia Mallett: Using short peptide-based technology to specifically target mTOR signalling in a neuronal model
6. Aimy Paul: Using short peptide-based technology to specifically target mTOR signalling in a neuronal model
7. Eleanor Cain: Targeting PSMA with Peptide Inhibitors: Precision Therapy for Prostate Cancer

2024/2025

1. Hannah Stephenson: Non-invasive Therapy for Soft Tissue Reconstruction - Aesthetic Applications
2. Carys Hockley: Peptide-Based Hydrogels as Novel Systems for Prostate-Specific Membrane Antigen (PSMA)
3. Olivia Killen: Delivering Cell Penetrating Peptides Non-Invasively into the Brain to Target Glial-Related Brain Diseases and as Antimicrobial Agents

MRes Students

2024/2025

1. Amabella Lim: Non-invasive Therapy for Soft Tissue Reconstruction - Therapeutic Applications
2. Pallavi Gupta: Peptide-based Drug for Microneedles Applications

Connect

Stage 1

• Acid-base 1-2
• Acid-base 3-4
• Thermodynamics 1
• Thermodynamics 2
• Thermodynamics 3
• Volumetric Titrations
• Synthesis of Paracetamol
• Hydrolysis of Aspirin

Stage 2

• Antibiotic Chemistry
• Antibiotic Chemistry Seminar
• Drug Likeness and Druggability
• Case study - GI drugs
• Physicochemical Properties 1
• Physicochemical Properties 2
• Case study - Salbutamol / Salmeterol
• Mini Project Tutorial 2
• Synthesis of Sulfonamides

Stage 3

• Chemistry of Sildenafil: case study

Stage 4

• Mechanistic basis of antibacterial therapy
• Antibacterial chemistry seminar
• Mechanistic basis of chemotherapy 1
• Mechanistic basis of chemotherapy 2
• Mechanistic basis of chemotherapy 3
• PARP inhibitors
• Chemotherapy chemistry seminar
• Development of TKIs

• Articles

  • Fares M, Al Musaimi O. . Journal of Peptide Science 2026, 32(6), e70101.
  • Al Musaimi, O. Racemisation of Amino Acids: From Synthetic Challenge to Biological Significance. ChemBioChem 2026, 27, e70409.
  • Adam, H, Abdollahi, S, Al Musaimi, O. Peptide-Based Delivery Systems: Selected Insights into Cell-Penetrating Peptides. Acs Chemical Neuroscience 2026.
  • Al Musaimi O, Williams DR. . ACS Bio & Med Chem Au 2026, 6(1), 90-100.
  • Stephenson H, Lim A, Dupuy R, Brun S, Armstrong A, Okunola N, Li NA, Hilkens CMU, Novakovic K, Hills S, Ng KW, Al Musaimi O. . International Journal of Pharmaceutics 2026, 689, 126490.
  • AlShaer D, Al Musaimi O, Albericio F, de la Torre B. . Pharmaceuticals 2026, 19(2), 244.
  • Al Musaimi, O. . Int. J. Environ. Res. Public Health 2025, 22, 750.
  • Armstrong A, Coburn F, Nsereko Y, Al Musaimi O. . Journal of Peptide Science 2025, 31(8), e70040.
  • Chatzilakou E, Hu Y, Al Musaimi O, Valenzo O, Jiang N, Williams DR, Yetisen AK. . Bioconjugate Chemistry 2025, 36(11), 2357-2369.
  • Coburn F, Nsereko Y, Armstrong A, Al Musaimi O. . European Journal of Medicinal Chemistry 2025, 297, 117961.
  • Armstrong A, Coburn F, Nsereko Y, Al Musaimi O. . International Journal of Molecular Sciences 2025, 26(14), 6815.
  • Al Musaimi O. . Antibiotics 2025, 14(2), 166.
  • Al Musaimi O, Alshaer D, de la Torre BG, Albericio F. . Pharmaceuticals 2025, 18(3), 291.
  • Al Musaimi O. . International Journal of Peptide Research and Therapeutics 2024, 30, 56.
  • Al Musaimi O, Tomkins J, Barry SM, Basso A, Kou X, Zhang C, Serban S. . RSC Advances 2024, 54.
  • Zulfiqar N, Nadeem R, Al Musaimi O. . ACS Omega 2024, 9(7), 7986-8004.
  • Al Musaimi O. . Cancers 2024, 16(5), 1032.
  • Al Musaimi O. . Medicinal Chemistry Research 2024, 33, 2204–2220.
  • Al Musaimi O. . Peptides 2024, 182, 171317.
  • Al Musaimi O. . Journal of Peptide Science 2024, 30(11), e3627.
  • Al Musaimi, O. . Biomolecules 2024, 14(3), 264.
  • Dickerson H, Diab A, Al Musaimi O. . International Journal of Molecular Sciences 2024, 25(18), 10008.
  • Al Musaimi O, Ng KW, Gavva V, Valenzo OMM, Haroon HB, Williams DR. . Gels 2024, 10(8), 531.
  • Al Musaimi O, Jaradat Da’san M M. . Separations 2024, 11(8), 233.
  • Al Musaimi O, Al Shaer D, Albericio F, de la Torre BG. . Pharmaceuticals 2024, 17(2), 243.
  • Al Musaimi O, Morse SV, Lombardi L, Serban S, Basso A, Williams DR. . Peptide Science 2023, 29(2), e3448.
  • Gavva V, Al Musaimi O, Bent C, Williams DR. . Separations 2023, 10(8), 456.
  • Al Musaimi O, Gavva V, Williams DR. . ChemistryOpen 2022, 11(12), e202200236.
  • Jaradat DMM, Al Musaimi O, Albericio F. . Green Chemistry 2022, 24(17), 6360-6372.
  • Al Musaimi O, Wisdom R, Talbiersky P, de la Torre BG, Albericio F. . ChemistrySelect 2021, 6(11), 2649-2657.
  • Al Musaimi O, Al Shaer D, Albericio F, de la Toree BG. . Pharmaceuticals 2021, 14(2), 145.
  • Al Musaimi, O. Greening Fmoc/tBu solid-phase peptide synthesis. Green Chemistry 2020, 22, 996-1018.
  • Al Shaer D, Al Musaimi O, Albericio F, de la Toree B G. 2019 FDA TIDES (peptides and oligonucleotides) harvest. Pharmaceuticals 2019, 13(3), 40.

• Patents

  • Othman, Al. Solution Phase Peptide Synthesis. GB2409647.1, 2024. Submitted.
  • Al Musaimi O, Williams DR. . WO2024261319A1, 07/12/2024.
  • Al Musaimi O, Williams DR. Methods of Chemical Synthesis of Oligonucleotides. 2415649.9, 2024. Submitted.
  • Al Musaimi O, Williams D R. Methods of Chemical Synthesis of Peptides. UK, GB2312735.0, 2023. Submitted.

• Review

  • Diab A, Dickerson H, Al Musaimi O. . Pharmaceuticals 2025, 18(1), 70.